A significant risk of metabolic dysfunction-associated fatty liver disease plus diabetes on subclinical atherosclerosis

BACKGROUND: This cross-sectional study aims to investigate the association between subclinical atherosclerosis and metabolic dysfunction-associated fatty liver disease (MAFLD) or non-alcoholic fatty liver disease (NAFLD), and a synergistic effect of diabetes mellitus (DM) and MAFLD on subclinical at...

Descripción completa

Detalles Bibliográficos
Autores principales: Bessho, Rieko, Kashiwagi, Kazuhiro, Ikura, Akihiko, Yamataka, Karin, Inaishi, Jun, Takaishi, Hiromasa, Kanai, Takanori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9154100/
https://www.ncbi.nlm.nih.gov/pubmed/35639744
http://dx.doi.org/10.1371/journal.pone.0269265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9154100/
https://www.ncbi.nlm.nih.gov/pubmed/35639744
http://dx.doi.org/10.1371/journal.pone.0269265

Ejemplares similares